BRCA germline mutations in women with uterine serous carcinoma-still a debate

O Lavie, A Ben-Arie, Y Segev, J Faro, F Barak… - International Journal of …, 2010 - ijgc.bmj.com
Objective: To determine the incidence of BRCA1 and BRCA2 mutations in an enlarged series
of uterine serous carcinoma (USC) patients and to determine whether patients with USC …

[HTML][HTML] Pain control in ambulatory cancer patients—can we do better?

P Shvartzman, M Friger, A Shani, F Barak… - Journal of pain and …, 2003 - Elsevier
To evaluate the degree of pain control among ambulatory cancer patients visiting the outpatient
clinics of three oncology centers in south Israel, these patients were interviewed using …

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation: association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in …

…, E Azizi, I Molchadski, G Galore-Haskel, F Barak… - Journal of …, 2009 - Springer
Background A single missense mutation (G2019S) in the leucine rich repeat kinase 2 (LRRK2)
gene has been reported to be prevalent among Ashkenazi Jewish patients with …

Physical health and cognition

S Kreitler, K Weissler, F Barak - Cognition and motivation …, 2013 - books.google.com
This chapter deals with the impact of physical health on cognition. There are several lines of
research and thinking that support the conception that physical health may be an important …

The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients

F Barak, R Milgrom, Y Laitman, O Gemer… - Gynecologic …, 2010 - Elsevier
OBJECTIVES: The genes associated with familial Endometrial Cancer (EC) are largely
unknown. While EC is an integral part of Hereditary Non-Polyposis Colon Cancer, there is an …

MC1R variant alleles and malignant melanoma risk in Israel

…, A Scope, V Chaudru, Y Laitman, F Barak… - European Journal of …, 2009 - Elsevier
To evaluate the contribution of MC1R variants to malignant melanoma risk in Israeli Jews,
sequencing of the MC1R gene was performed in 132 melanoma patients and 184 ethnically …

The influence of early diagnosis of endometrioid endometrial cancer on disease stage and survival

F Barak, L Kalichman, M Gdalevich, R Milgrom… - Archives of gynecology …, 2013 - Springer
Objective To evaluate whether the presence or duration of uterine bleeding is associated
with disease stage, and survival of patients with endometrioid endometrial carcinoma (EEC). …

Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers.

…, LH Katz, E Pras, L Ries-Levavi, F Barak… - The Israel Medical …, 2017 - europepmc.org
Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

The Founder Mutations in the BRCA1, BRCA2, and ATM Genes in Moroccan Jewish Women with Breast Cancer

Y Kreiss, F Barak, RG Baruch, E Levy-Lahad… - Genetic …, 2000 - liebertpub.com
To gain insight into the molecular mechanisms underlying the inherited predisposition to
breast cancer in non-Ashkenazi Jews, we genotyped 54 Jewish Moroccan women with breast …

Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: Tolerability and efficacy study—The Israeli experience

…, A Yachnin, I Bruchim, M Meirovitz, F Barak… - International Journal of …, 2013 - ijgc.bmj.com
Objectives The purpose of this study was to assess the clinical activity and toxicity of weekly
topotecan in a large cohort of epithelial ovarian (EOC), primary peritoneal (PPC), and tubal …